文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

慢性肝病死亡率的时间趋势和差异:一项使用美国国家卫生统计中心(NCHS)1999年至2023年数据的分析

Temporal Trends and Disparities in Chronic Liver Disease Mortality: An Analysis Using National Center for Health Statistics (NCHS) Data Ranging From 1999 to 2023.

作者信息

Ezeamii Victor C, Arinzechi Chukwujindu I, Oghotuoma Oghenemaro O, Umoudoh Uwakmfonabasi, Adebayo Afolake A, Nnabude Ogechukwu H, Ajani Taiwo, Ayinde Bolaji, Anyaorah Chinelo, Ojukwu Gift

机构信息

Public Health, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, USA.

Internal Medicine, May Pen Hospital, May Pen, JAM.

出版信息

Cureus. 2025 May 12;17(5):e83957. doi: 10.7759/cureus.83957. eCollection 2025 May.


DOI:10.7759/cureus.83957
PMID:40510081
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12158815/
Abstract

BACKGROUND: Chronic liver disease (CLD) remains a significant global health concern, with fluctuating mortality trends over the past two decades. This study analyzes age-adjusted CLD mortality rates using data from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) from 1999 to 2023, highlighting temporal trends and demographic disparities. METHODS: We conducted a retrospective analysis of CLD mortality rates stratified by year, gender, race, age group, and Hispanicity. Age-adjusted mortality rates were computed using direct standardization, and trends were examined over different periods. RESULTS: Between 1999 and 2006, CLD mortality rates declined from 9.6 to 8.8 per 100,000 population. However, from 2007 onward, mortality rates increased, peaking at 14.5 in 2021, largely driven by the COVID-19 pandemic. Males exhibited consistently higher mortality rates than females. Racial disparities were evident, with American Indian/Alaska Native populations experiencing the highest mortality rates. Age-related trends showed the greatest burden in older adults, while mortality rates in younger populations also rose in recent years. Hispanic individuals demonstrated a significant increase in CLD mortality, particularly post-2010. CONCLUSION: CLD mortality has risen significantly since 2007, with a pronounced peak in 2021. Despite a post-pandemic decline, rates remain above pre-2019 levels. These findings emphasize the significance of customized public health interventions and strategies tackling alcohol use, various metabolic risk factors, and healthcare access, especially for high-risk individuals and populations.

摘要

背景:慢性肝病(CLD)仍然是一个重大的全球健康问题,在过去二十年中死亡率呈波动趋势。本研究使用疾病控制与预防中心的广泛流行病学研究在线数据(CDC WONDER)1999年至2023年的数据,分析了年龄调整后的CLD死亡率,突出了时间趋势和人口统计学差异。 方法:我们对按年份、性别、种族、年龄组和西班牙裔分层的CLD死亡率进行了回顾性分析。使用直接标准化计算年龄调整后的死亡率,并在不同时期检查趋势。 结果:1999年至2006年期间,CLD死亡率从每10万人9.6例降至8.8例。然而,从2007年起,死亡率上升,在2021年达到峰值14.5例,主要由新冠疫情驱动。男性的死亡率一直高于女性。种族差异明显,美国印第安人/阿拉斯加原住民的死亡率最高。与年龄相关的趋势显示老年人负担最重,而近年来年轻人群的死亡率也有所上升。西班牙裔个体的CLD死亡率显著增加,尤其是在2010年之后。 结论:自2007年以来,CLD死亡率显著上升,2021年达到明显峰值。尽管疫情后有所下降,但仍高于2019年前的水平。这些发现强调了定制公共卫生干预措施和应对酒精使用、各种代谢风险因素以及医疗保健可及性的策略的重要性,特别是针对高危个体和人群。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bad9/12158815/b2246babfc50/cureus-0017-00000083957-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bad9/12158815/7ddc9af190d9/cureus-0017-00000083957-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bad9/12158815/915f424219b1/cureus-0017-00000083957-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bad9/12158815/e5414c15880e/cureus-0017-00000083957-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bad9/12158815/b2246babfc50/cureus-0017-00000083957-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bad9/12158815/7ddc9af190d9/cureus-0017-00000083957-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bad9/12158815/915f424219b1/cureus-0017-00000083957-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bad9/12158815/e5414c15880e/cureus-0017-00000083957-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bad9/12158815/b2246babfc50/cureus-0017-00000083957-i04.jpg

相似文献

[1]
Temporal Trends and Disparities in Chronic Liver Disease Mortality: An Analysis Using National Center for Health Statistics (NCHS) Data Ranging From 1999 to 2023.

Cureus. 2025-5-12

[2]
Epidemiology of elderly burn patients in the United States: Mortality patterns and risk factors revealed by CDC WONDER database.

Burns. 2025-2

[3]
Trends and Patterns in Hypertension-Related Deaths: A Comprehensive Analysis Using Center for Disease Control and Prevention's Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) Data.

Cureus. 2024-10-3

[4]
Trends and Patterns in Obesity-Related Deaths in the US (2010-2020): A Comprehensive Analysis Using Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) Data.

Cureus. 2024-9-1

[5]
Trends and Disparities in Pneumonia-Related Mortality in the U.S. Population: A Nationwide Analysis Using the CDC WONDER Data.

Cureus. 2025-5-2

[6]
Chronic Liver Disease and Cirrhosis Mortality Rates Are Disproportionately Increasing in Younger Women in the United States Between 2000-2020.

Clin Gastroenterol Hepatol. 2024-4

[7]
Temporal Trends in Racial and Gender Disparities of Early Onset Colorectal Cancer in the United States: An Analysis of the CDC WONDER Database.

J Gastrointest Cancer. 2024-12

[8]
Burden of liver cancer mortality by county, race, and ethnicity in the USA, 2000-19: a systematic analysis of health disparities.

Lancet Public Health. 2024-3

[9]
Impact of the COVID-19 pandemic on liver disease-related mortality rates in the United States.

J Hepatol. 2023-1

[10]
Trends of Mortality due to Traumatic Brain Injury in the USA: A Comprehensive Analysis of CDC WONDER Data from 1999 to 2020.

Asian J Neurosurg. 2024-12-12

本文引用的文献

[1]
Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions.

Nat Rev Gastroenterol Hepatol. 2024-12

[2]
Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction.

Cell Mol Life Sci. 2024-1-12

[3]
Oxidative Stress in Liver Pathophysiology and Disease.

Antioxidants (Basel). 2023-8-22

[4]
Chronic Liver Disease: Latest Research in Pathogenesis, Detection and Treatment.

Int J Mol Sci. 2023-6-25

[5]
Epidemiology and Disease Burden of Alcohol Associated Liver Disease.

J Clin Exp Hepatol. 2023

[6]
Sex differences matter: Males and females are equal but not the same.

Physiol Behav. 2023-2-1

[7]
Covid-19 and alcohol associated liver disease.

Dig Liver Dis. 2022-11

[8]
Nutrition as Therapy in Liver Disease.

Clin Ther. 2022-5

[9]
Hepatic stellate cells in physiology and pathology.

J Physiol. 2022-4

[10]
Impact of COVID-19 in Liver Disease Progression.

Hepatol Commun. 2021-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索